N=1 Collaborative appoints Hugh Hempel as first Executive Director to advance rare disease therapies and promote global collaborations.

The N=1 Collaborative (N1C) has named Hugh Hempel as its first Executive Director. With a strong background in rare disease healthcare, Hempel will lead efforts to enhance access to therapies for rare disease patients and promote global collaborations for individualized medicine development. His leadership aims to engage stakeholders across the healthcare spectrum to create standardized frameworks for genetic treatments.